Thank you. We appreciate that.
I come now to Mr. Frank.
I think you were present in the room when I asked the minister about the notion around choice and whether this undermines the choice that Canadians would have, or in fact enhances the choice that's available to them. He was very clear that the choice will be maintained and that people would have the choice, that this is really creating a floor on two sets of drugs and that there is an important role for the private health care systems that you are representing.
You in your presentation still made an argument in talking about practical and legal barriers, and I'd like you to elaborate as to what you think they are. Are you not satisfied, after listening to the minister, that the choice that Canadians have available right now will not be impacted by this legislation?